149 related articles for article (PubMed ID: 27684188)
21. A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.
Hassantoufighi A; Zhang H; Sandbulte M; Gao J; Manischewitz J; King L; Golding H; Straight TM; Eichelberger MC
Vaccine; 2010 Jan; 28(3):790-7. PubMed ID: 19887135
[TBL] [Abstract][Full Text] [Related]
22. Determination of the sialic acid linkage specificity of sialidases using lectins in a solid phase assay.
Rogerieux F; Belaise M; Terzidis-Trabelsi H; Greffard A; Pilatte Y; Lambré CR
Anal Biochem; 1993 Jun; 211(2):200-4. PubMed ID: 7686353
[TBL] [Abstract][Full Text] [Related]
23. Neuraminidase assays.
Aymard M; Ferraris O; Gerentes L; Jolly J; Kessler N
Dev Biol (Basel); 2003; 115():75-83. PubMed ID: 15088778
[TBL] [Abstract][Full Text] [Related]
24. Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.
da Costa KAS; Del Rosario JMM; Ferrari M; Vishwanath S; Asbach B; Kinsley R; Wagner R; Heeney JL; Carnell GW; Temperton NJ
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146598
[TBL] [Abstract][Full Text] [Related]
25. Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.
Sultana I; Gao J; Markoff L; Eichelberger MC
Vaccine; 2011 Mar; 29(14):2601-6. PubMed ID: 21288802
[TBL] [Abstract][Full Text] [Related]
26. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.
Pedersen JC
Methods Mol Biol; 2014; 1161():27-36. PubMed ID: 24899417
[TBL] [Abstract][Full Text] [Related]
27. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
[TBL] [Abstract][Full Text] [Related]
28. Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.
Wan H; Sultana I; Couzens LK; Mindaye S; Eichelberger MC
J Virol Methods; 2017 Jun; 244():23-28. PubMed ID: 28257802
[TBL] [Abstract][Full Text] [Related]
29. A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test.
Avellaneda G; Sylte MJ; Lee CW; Suarez DL
Avian Dis; 2010 Mar; 54(1 Suppl):272-7. PubMed ID: 20521644
[TBL] [Abstract][Full Text] [Related]
30. Stability of neuraminidase in inactivated influenza vaccines.
Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
[TBL] [Abstract][Full Text] [Related]
31. Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay.
Gavrilov V; Orekov T; Alabanza C; Porika U; Jiang H; Connolly K; Pincus S
J Virol Methods; 2011 May; 173(2):364-73. PubMed ID: 21419169
[TBL] [Abstract][Full Text] [Related]
32. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
33. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
Smith GE; Sun X; Bai Y; Liu YV; Massare MJ; Pearce MB; Belser JA; Maines TR; Creager HM; Glenn GM; Flyer D; Pushko P; Levine MZ; Tumpey TM
Virology; 2017 Sep; 509():90-97. PubMed ID: 28624679
[TBL] [Abstract][Full Text] [Related]
36. Rapid enzymologic anti-neuraminidase antibody microtest.
Thraenhart O; Kuwert EK
Dev Biol Stand; 1977 Jun 1-3; 39():475-80. PubMed ID: 604134
[TBL] [Abstract][Full Text] [Related]
37. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy.
Liu Y; Mundt E; Mundt A; Sylte M; Suarez DL; Swayne DE; García M
Avian Dis; 2010 Mar; 54(1 Suppl):613-21. PubMed ID: 20521703
[TBL] [Abstract][Full Text] [Related]
39. Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection.
Li X; Fang F; Song Y; Yan H; Chang H; Sun S; Chen Z
DNA Cell Biol; 2006 Apr; 25(4):197-205. PubMed ID: 16629592
[TBL] [Abstract][Full Text] [Related]
40. Influenza neuraminidase as a vaccine antigen.
Eichelberger MC; Wan H
Curr Top Microbiol Immunol; 2015; 386():275-99. PubMed ID: 25033754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
